Opyl Secures First TrialGen Contract With Brain Vector

Digital health company Opyl (ASX:OPL) secured a contract with mental healthcare firm Brain Vector for the former's AI-driven TrialGen platform, according to a Thursday filing with the Australian Secur

MT NewswiresJun 5 22:42 ET

Opyl Ltd. Advises Investor Caution and Diligence

TipRanksMay 7 00:17 ET

Opyl Ltd Announces Director's Final Interests

TipRanksMay 1 22:17 ET

Opyl Ltd. Advances AI Platform and Streamlines Business

TipRanksApr 30 01:08 ET

Opyl Ltd. Calls for Virtual General Meeting

TipRanksApr 28 23:57 ET

Opyl Expands TrialKey Coverage; Shares Up 38%

Digital health company Opyl (ASX:OPL) expanded its TrialKey.ai platform, increasing its coverage to 350,000 trials from 65,000 and enhancing its ability to predict and optimize clinical research and d

MT NewswiresApr 28 21:40 ET